Myoderm unveils drug procurement, management and distribution service
Myoderm, a US supplier of drugs for clinical research and clinical trials, is offering a new distribution management services capability, which provides clients with a system for sourcing, managing and distributing off-the-shelf, commercial drugs used in clinical trials.
Myoderm, a US supplier of drugs for clinical research and clinical trials, is offering a new distribution management services capability, which provides clients with a system for sourcing, managing and distributing off-the-shelf, commercial drugs used in clinical trials.
The company says it is a cost-effective alternative to site or patient reimbursement of commercially sourced drugs.
Myoderm's employees have extensive project management and logistics expertise, newly constructed state-of-the-art distribution facilities, and proprietary technology to support clients' clinical supply planning, management, and sourcing.
Mike Cohen, Myoderm's managing director, said: "Our customers will be able to diminish logistical complexities, reduce exposure to waste, greatly improve traceability and control of their drug supplies, and more easily and cost-effectively achieve the time and cost benchmarks of their trials."